NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)

NCT05189925 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

25

Enrollment

NIH

Sponsor class

Conditions

Chronic Granulomatous Disease
Infection

Interventions

BIOLOGICAL: gp91 Grans

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)